9 Meters Biopharma, Inc.
NMTRDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001551986
9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in 9 Meters Biopharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- −1 vs. Q3 2021
- Shares held
- 78.9M
- +6.29M (+8.7%) vs. Q3 2021
- Total value
- $76.8M
- −$17.5M (−18.6%) vs. Q3 2021
- New holders
- 13
- 33 more added
- Sold out
- 14
- 27 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $6.43K |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 6 | $22.7K |
| Q2 2023 | 34 | $2.08M |
| Q1 2023 | 39 | $4.45M |
| Q4 2022 | 42 | $3.02M |
| Q3 2022 | 74 | $10.4M |
| Q2 2022 | 88 | $15.2M |
| Q1 2022 | 101 | $45.2M |
| Q4 2021 | 104 | $76.8M |
| Q3 2021 | 105 | $94.2M |
| Q2 2021 | 99 | $81.8M |
| Q1 2021 | 90 | $88.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding 9 Meters Biopharma, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 10,275,887 | $10.1M | 0.13% | +1,709,913+20.0% | Added |
| Vanguard Group Inc | 11,844,484 | $11.6M | 0.00% | +174,816+1.5% | Added |
| BlackRock Inc. | 14,164,801 | $13.9M | 0.00% | +598,536+4.4% | Added |
| Adage Capital Partners GP, L.L.C. | 15,000,000 | $14.7M | 0.03% | 00.0% | Unchanged |
| Chartwell Investment Partners, LLC | 0 | $0 | 0.00% | −475,839−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −315,867−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −84,767−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −64,133−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −32,600−100.0% | Sold out |
| Paradigm, Strategies in Wealth Management, LLC | 0 | $0 | 0.00% | −30,800−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −24,834−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −10,900−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −5,293−100.0% | Sold out |
| MCF Advisors LLC | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −20−100.0% | Sold out |